SE7609339L - PHARMACEUTICAL BASE SALTS - Google Patents
PHARMACEUTICAL BASE SALTSInfo
- Publication number
- SE7609339L SE7609339L SE7609339A SE7609339A SE7609339L SE 7609339 L SE7609339 L SE 7609339L SE 7609339 A SE7609339 A SE 7609339A SE 7609339 A SE7609339 A SE 7609339A SE 7609339 L SE7609339 L SE 7609339L
- Authority
- SE
- Sweden
- Prior art keywords
- base salts
- pharmaceutical base
- pharmaceutical
- salts
- base
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3529575A GB1563390A (en) | 1975-08-27 | 1975-08-27 | Pharmaceutical products |
GB3529675 | 1975-08-27 | ||
GB2396276 | 1976-06-10 | ||
GB2396376 | 1976-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7609339L true SE7609339L (en) | 1977-02-28 |
Family
ID=27448608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7609339A SE7609339L (en) | 1975-08-27 | 1976-08-23 | PHARMACEUTICAL BASE SALTS |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5254014A (en) |
CH (1) | CH621940A5 (en) |
DE (1) | DE2636559C2 (en) |
IL (1) | IL50250A (en) |
SE (1) | SE7609339L (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (en) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | eye drops |
GB2013084B (en) * | 1978-01-25 | 1982-07-28 | Alcon Lab Inc | Ophthalmic drug dosage |
HU187313B (en) * | 1980-10-03 | 1985-12-28 | Andras Sugar | Dental cosmetic prparation |
IL61721A (en) * | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
US4539199A (en) * | 1981-01-14 | 1985-09-03 | Egyt Gyogyszervegyeszeti Gyar | Sustained release pharmaceutical compositions |
EP0103970A3 (en) * | 1982-08-20 | 1985-05-22 | LAWRENCE, Peter Robin Broughton | Amine salts and products containing them |
AU563054B2 (en) * | 1984-10-24 | 1987-06-25 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneous tape of isdn |
CA1295941C (en) * | 1985-08-16 | 1992-02-18 | Rajan Bawa | Sustained-release formulation comprising a hydrophobic polymer system |
JPS63503540A (en) * | 1986-05-29 | 1988-12-22 | フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ | Anti-tumor film made of biodegradable polymer |
DE19508029C2 (en) * | 1995-03-07 | 1997-10-09 | Richard Prof Dr Sueverkruep | Dosage form for external application of ophthalmic medicinal substances and method for the production thereof |
US5972326A (en) * | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
US5888494A (en) * | 1996-03-12 | 1999-03-30 | Adolor Corporation | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
EP0934082B1 (en) * | 1996-10-23 | 2002-07-17 | SKW Trostberg Aktiengesellschaft | Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
DE19753298A1 (en) * | 1997-12-01 | 1999-06-02 | Basf Ag | Process for the preparation of solid dosage forms |
DK172900B1 (en) * | 1998-12-18 | 1999-09-27 | Per Julius Nielsen | Preparation and kit for use in intraocular surgery |
JP5209827B2 (en) * | 2011-03-18 | 2013-06-12 | 株式会社シード | Drug sustained-release medical device |
JP2017080303A (en) * | 2015-10-30 | 2017-05-18 | 日油株式会社 | Medicine sustained release medical use contact lens |
SG11202004019SA (en) | 2017-11-17 | 2020-05-28 | Cellix Bio Private Ltd | Compositions and methods for the treatment of eye disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2229984A1 (en) * | 1972-06-20 | 1974-01-10 | Kraemer Kg Wilhelm | FASTENING DEVICE FOR A BATTERY-FEED WARNING LAMP |
DE2246037B2 (en) * | 1972-09-20 | 1975-02-27 | Taeschner & Co, 8831 Kipfenberg | Orally applicable drug with delayed absorption in suspension form |
-
1976
- 1976-08-12 IL IL50250A patent/IL50250A/en unknown
- 1976-08-13 DE DE2636559A patent/DE2636559C2/en not_active Expired
- 1976-08-23 SE SE7609339A patent/SE7609339L/en unknown
- 1976-08-26 JP JP51101173A patent/JPS5254014A/en active Pending
- 1976-08-27 CH CH1090876A patent/CH621940A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS5254014A (en) | 1977-05-02 |
IL50250A0 (en) | 1976-10-31 |
IL50250A (en) | 1980-01-31 |
DE2636559C2 (en) | 1985-10-31 |
CH621940A5 (en) | 1981-03-13 |
DE2636559A1 (en) | 1977-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK533476A (en) | CAPSULES | |
BE840307A (en) | CARBODIMIDES | |
DK115376A (en) | KINOLON DERIVATIVES | |
BR7600226A (en) | MEDICATION SET | |
SE7601274L (en) | ISOXAZOLYLBENSAMIDE DERIVATIVES | |
SE7609339L (en) | PHARMACEUTICAL BASE SALTS | |
AT350119B (en) | TIME BASE COMPENSATION CIRCLE | |
DK116576A (en) | SALICYLANILIDE DERIVATIVES | |
SE7505163L (en) | TORNESCHOKE FOR HAGELVAPEN | |
NO146045C (en) | ORAL ROENTGENCONTRACTOR FOR CHOLECYSTANGIOGRAPHY | |
SE408266B (en) | DRUG EVAPORATORS | |
SE416860B (en) | PLAN RADARANTENN | |
SE408126B (en) | BERBAND FOR BLIXTLAS | |
SE7608478L (en) | PHARMACEUTICAL | |
SE414700B (en) | articulator | |
SE423038B (en) | DRUGS WITH SHUNTSTROM | |
SE7609476L (en) | BERKONSTRUCTION FOR BERGTUNNLAR | |
FI773812A (en) | PHARMACEUTICAL FORM | |
SE411166B (en) | BERBAND FOR BLIXTLAS | |
FR2318781A1 (en) | BOLLARD | |
FI65878B (en) | VERTICAL AVBOEJNINGSKRETS | |
SE7613797L (en) | CYPROHEPTADIN DERIVATIVES | |
FR2301854A1 (en) | Dis | |
FI773813A (en) | PHARMACEUTICAL FORM | |
RO75865A (en) | CONSISTENT UNIQUE |